Friday, 29 March 2024
Nymox Pharmaceutical Corporation
NASDAQ : NYMX
0.3294 14 Oct 22 00:00 | Change: 0.01 | Open: 0.3500 | High: 0.3500 | Ask: 6.0100 | Volume: 88,200 |
Change(%): 1.67 | Prev: 0.3350 | Low: 0.3200 | Bid: 5.6500 | Avg vol: 0 |
04:11 | 19/3/18
Macon Daily
Nymox Pharmaceutical logo Nymox Pharmaceutical Co. (NASDAQ:NYMX) Director James George Robinson bought 8,000 shares of Nymox Pharmaceutical stock in a transaction dated Thursday, March 15th. The stock was purchased at an average price of $3.58 per ...
more»
14:18 | 14/3/18
Wall Street Herald
Here we will take a look at several key ratios for Nymox Pharmaceutical Corporation (NasdaqCM:NYMX), starting with the Book to Market (BTM) ratio.
more»
01:15 | 14/3/18
Post Analyst
Mar 12 was a strong volume day for Nymox Pharmaceutical Corporation (NASDAQ:NYMX), with an upside momentum. The trading capacity for the firm moved to 0.22 million contracts.
more»
06:15 | 9/3/18
Frisco Fastball
More notable recent Nymox Pharmaceutical Corporation (NASDAQ:NYMX) news were published by: Seekingalpha.com which released: “Nymox Pharmaceutical May Have The Best Risk/Reward Profile In Biotech” on February 28, 2018, also Seekingalpha.
more»
No Risk Alert Here: Before we dive into any analysis we simply note that Nymox Pharmaceutical Corporation (NASDAQ:NYMX) risk is neither elevated nor depressed.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |